Growth Metrics

Eton Pharmaceuticals (ETON) Change in Receivables (2020 - 2025)

Eton Pharmaceuticals' Change in Receivables history spans 6 years, with the latest figure at -$1.3 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 241.11% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.4 million, a 105.13% increase, with the full-year FY2025 number at $6.4 million, up 105.13% from a year prior.
  • Change in Receivables hit -$1.3 million in Q4 2025 for Eton Pharmaceuticals, up from -$1.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for ETON hit a ceiling of $11.0 million in Q1 2025 and a floor of -$4.7 million in Q1 2022.
  • Historically, Change in Receivables has averaged $643850.0 across 5 years, with a median of $303000.0 in 2021.
  • Biggest five-year swings in Change in Receivables: soared 10495.83% in 2021 and later plummeted 1955.16% in 2022.
  • Tracing ETON's Change in Receivables over 5 years: stood at $5.1 million in 2021, then plummeted by 93.04% to $354000.0 in 2022, then crashed by 123.73% to -$84000.0 in 2023, then skyrocketed by 1217.86% to $939000.0 in 2024, then tumbled by 241.11% to -$1.3 million in 2025.
  • Business Quant data shows Change in Receivables for ETON at -$1.3 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.9 million in Q2 2025.